← Back to Clinical Trials
Recruiting NCT06622993

NCT06622993 Effectiveness of the SKILLS Program in the Management of Psychiatric Disorders

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06622993
Status Recruiting
Phase
Sponsor University Hospital, Tours
Condition Psychiatric Disorders
Study Type INTERVENTIONAL
Enrollment 60 participants
Start Date 2024-11-14
Primary Completion 2026-11

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 100 Years
Study Type INTERVENTIONAL
Interventions
Psychotherapy

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 60 participants in total. It began in 2024-11-14 with a primary completion date of 2026-11.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Epidemiological studies show that one person in eight suffers from at least one psychiatric disorder. Mental health is therefore a major public health issue, and care for these disorders must continue to be improved. The management of mental disorders has long followed the traditional categorical approach of developing a treatment for a given disorder. However, researchers have recently pointed out the limits of this approach in the field of mental health. They highlight the large number of co-morbidities, the existence of aspecific disorders and the intra-diagnostic heterogeneity of patients. These factors have led them to develop a transdiagnostic approach, which focuses on the mechanisms common to the various disorders in order to treat them at the same time and thus reduce the cost of treatment.

Eligibility Criteria

Inclusion Criteria: * Male or female ≥ 18 years of age * Have at least one diagnosis of a psychiatric disorder * Be able to carry out psychotherapy sessions * Have been on stable psychiatric medication for 30 days * Written informed consent obtained from the participant * Be affiliated to a social security scheme or equivalent Exclusion Criteria: * Cognitive deficits marked by a score above the 10th percentile for one or more tests in the assessment history. * Persons deprived of liberty by judicial or administrative decision; Persons under legal protection: guardianship or curatorship * Presence of a severe depressive episode * Be engaged in psychotherapeutic work elsewhere * Presence of a state of excessive deficit, making psychotherapy impossible * Presence of psychic decompensation (e.g. delusions) making psychotherapy impossible

Contact & Investigator

Central Contact

VANCAPPEL

✉ alexis.vancappel@univ-tours.fr

📞 +33247477111

Frequently Asked Questions

Who can join the NCT06622993 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 100 Years, studying Psychiatric Disorders. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06622993 currently recruiting?

Yes, NCT06622993 is actively recruiting participants. Contact the research team at alexis.vancappel@univ-tours.fr for enrollment information.

Where is the NCT06622993 trial being conducted?

This trial is being conducted at Tours, France.

Who is sponsoring the NCT06622993 clinical trial?

NCT06622993 is sponsored by University Hospital, Tours. The trial plans to enroll 60 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology